14th Annual Lynn Sage Breast Cancer Symposium
The Fairmont Chicago - October 4-7, 2012

The optimal management of breast cancer continues to evolve based on new research findings. A multidisciplinary team of medical, surgical and radiation oncologists, pathologists, plastic surgeons and genetic counselors are routinely involved in treatment planning for breast cancer patients. With the emergence of new prevention strategies, women at high risk of developing breast cancer are now evaluated for medical therapies, surgical options and lifestyle changes that may reduce their risk of developing breast cancer. With new information about the molecular makeup of the tumor, treatment options are individualized. The 14th Annual Lynn Sage Breast Cancer Symposium provides a forum for presenting laboratory and clinical research and discussing the care of patients with breast cancer. Various case studies will be presented and discussed throughout symposium utilizing an electronic Audience Response System.

At the conclusion of this symposium participants should be able to:

1. Determine the impact of co-morbidities on an elderly patients prognosis and appropriateness for systemic cancer therapy.
   
   
2. Explain the impact of cancer therapy on sexual function and satisfaction.
   
   
3. Realize the options and indications for neo-adjuvant therapy in locally advanced breast cancer.
   
   
4. Summarize the challenges and available options in treating triple negative breast cancer.
   
   
5. Identify new agents for overcoming endocrine resistance.
   
   
6. Evaluate the role of partial breast irradiation and compare this option to standard of care.
   
   
7. Review the treatment options for patient with ductal carcinoma in situ and how best to fit these treatment modalities to the appropriate individual.
   
   
8. Explain and review the role of meta-analysis in clarifying the activity of adjuvant therapies for breast cancer.